Niacin



Indications and Reactions:

Role Indications Reactions
Primary
Hyperlipidaemia 27.3%
Drug Use For Unknown Indication 21.0%
Blood Cholesterol Increased 15.4%
Product Used For Unknown Indication 10.5%
Blood Triglycerides Increased 4.2%
Dyslipidaemia 3.5%
Blood Cholesterol 2.8%
Rheumatoid Arthritis 2.8%
High Density Lipoprotein Increased 2.1%
Hypercholesterolaemia 2.1%
Lipids Abnormal 1.4%
Liver Disorder 1.4%
Blood Cholesterol Decreased 0.7%
Drug Abuse 0.7%
Drug Therapy Enhancement 0.7%
High Density Lipoprotein Abnormal 0.7%
High Density Lipoprotein Decreased 0.7%
Hypertension 0.7%
Hypertriglyceridaemia 0.7%
Ill-defined Disorder 0.7%
Flushing 19.0%
Rash 11.9%
Vomiting 10.7%
Rhabdomyolysis 6.0%
Weight Decreased 6.0%
Gout 4.8%
Intraocular Pressure Increased 4.8%
Dizziness 3.6%
Pruritus 3.6%
Skin Burning Sensation 3.6%
Urticaria 3.6%
Vision Blurred 3.6%
Dysgeusia 2.4%
Erythema 2.4%
Headache 2.4%
Hypersensitivity 2.4%
Loss Of Consciousness 2.4%
Malaise 2.4%
Myalgia 2.4%
Paraesthesia 2.4%
Secondary
Product Used For Unknown Indication 22.6%
Blood Cholesterol Increased 20.5%
Drug Use For Unknown Indication 10.7%
Hypertension 10.3%
High Density Lipoprotein Decreased 6.9%
Hyperlipidaemia 5.5%
Blood Triglycerides Increased 4.3%
Hypercholesterolaemia 2.8%
Blood Cholesterol 2.6%
Dyslipidaemia 1.7%
Type 2 Diabetes Mellitus 1.7%
Dementia Alzheimer's Type 1.5%
Diabetes Mellitus 1.4%
Low Density Lipoprotein Increased 1.4%
Atrial Fibrillation 1.3%
Benign Prostatic Hyperplasia 1.1%
Gastrooesophageal Reflux Disease 1.1%
Anticoagulant Therapy 0.9%
Hypothyroidism 0.9%
Arthralgia 0.8%
Rhabdomyolysis 19.7%
Drug Hypersensitivity 17.6%
Myalgia 5.9%
Weight Decreased 5.3%
Flushing 4.8%
Intraocular Pressure Increased 4.3%
Pruritus 4.3%
Renal Failure Acute 4.3%
Rash 3.7%
Vomiting 3.7%
Weight Increased 3.7%
Muscular Weakness 3.2%
Pain In Extremity 3.2%
Respiratory Arrest 3.2%
Insulin Autoimmune Syndrome 2.7%
Feeling Abnormal 2.1%
Hot Flush 2.1%
Hyperhidrosis 2.1%
Rash Generalised 2.1%
Rash Pruritic 2.1%
Concomitant
Product Used For Unknown Indication 32.7%
Drug Use For Unknown Indication 12.0%
Hypertension 7.9%
Blood Cholesterol Increased 6.2%
Type 2 Diabetes Mellitus 4.3%
Diabetes Mellitus 4.2%
Pain 3.5%
Prophylaxis 3.4%
Atrial Fibrillation 3.2%
Cardiac Disorder 2.7%
Vitamin Supplementation 2.5%
Rheumatoid Arthritis 2.4%
Osteoporosis 2.4%
Depression 2.3%
Gastrooesophageal Reflux Disease 2.1%
Blood Cholesterol 2.0%
Supplementation Therapy 1.9%
Hyperlipidaemia 1.6%
Anxiety 1.3%
Chronic Obstructive Pulmonary Disease 1.3%
Vomiting 12.4%
Weight Decreased 11.1%
Weight Increased 8.3%
Drug Ineffective 6.1%
Myocardial Infarction 5.5%
Nausea 5.0%
Pain 4.4%
Rash 4.2%
Pain In Extremity 4.0%
Vision Blurred 4.0%
Dyspnoea 3.9%
Death 3.7%
Myalgia 3.5%
Pruritus 3.5%
Urinary Tract Infection 3.5%
Wrong Technique In Drug Usage Process 3.5%
Fatigue 3.4%
Flushing 3.3%
Headache 3.3%
Renal Failure Acute 3.3%
Interacting
Antiretroviral Therapy 11.4%
Blood Cholesterol Increased 11.4%
Vitamin Supplementation 11.4%
Blood Cholesterol Abnormal 6.8%
Hypercholesterolaemia 6.8%
Smoking Cessation Therapy 6.8%
Vitamin D Deficiency 6.8%
Anticoagulant Therapy 4.5%
Blood Cholesterol Decreased 4.5%
High Density Lipoprotein Decreased 4.5%
Hypertension 4.5%
Major Depression 4.5%
Pulmonary Hypertension 4.5%
Cardiac Pacemaker Insertion 2.3%
Epilepsy 2.3%
Hiv Infection 2.3%
Hypothyroidism 2.3%
Type 2 Diabetes Mellitus 2.3%
Drug Interaction 22.7%
Vomiting 18.2%
International Normalised Ratio Increased 9.1%
Skin Reaction 9.1%
Vitamin D Deficiency 9.1%
Dizziness 4.5%
Drug Effect Decreased 4.5%
Hepatitis Acute 4.5%
Hyperhidrosis 4.5%
Injection Site Nodule 4.5%
Lipids Abnormal 4.5%
Obstructive Airways Disorder 4.5%